Atrial Fibrillation in Heart Failure Patients in the Cardiology Department of Ignace Deen University Hospital: Epidemiological, Clinical and Therapeutic Aspects
Introduction: Atrial fibrillation (AF) and heart failure (HF) are increasingly common cardiovascular diseases. They often occur together or lead to mutual complications. Patients with both conditions are at particular risk of cardiovascular complications, including all-cause death, cardiovascular death, stroke and worsening heart failure. Patients and Methods: A prospective, cross-sectional, descriptive study conducted over six months, from 1 April 2024 to 30 September 2024. All patients hospitalised in the department for heart failure and atrial fibrillation were eligible for the study. Sociodemographic, clinical, paraclinical and therapeutic data were collected. Results: Of the 372 patients included, 26.34% had AF, often associated with rheumatic valve disease. The mean age was 56.47 years, with females predominating. Therapeutic strategies focused on controlling heart rate, with extensive use of beta-blockers. Direct oral anticoagulants (DOACs) were the treatment of choice for thromboembolic prevention, despite access constraints. Conclusion: The high prevalence of AF in a relatively young population with little education highlights the need for prevention and early detection programmes targeting at-risk populations.
References
[1]
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J.J., et al. (2020) ESC Guidelines for the Diagnosis and Management of Atrial Fibrillation Developed in Collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 42, 373-498. https://doi.org/10.1093/eurheartj/ehaa945
[2]
Meiltz, A. and Zimmermann, M. (2009) Fibrillation auriculaire et respect des recommandations internationales au quoditien: Mythe ou réalité? Revue Médicale Suisse, 5, 520-525. https://doi.org/10.53738/revmed.2009.5.193.0520
[3]
Diop, K.R., Samb, C.A.B., Kane, A. and Mingou, J.S. (2022) Atrial Fibrillation in Three Dakar Referral Cardiology Centres: Senegalese Data from the AFRICA Registry Survey. Pan African Medical Journal, 43, 112.
[4]
Piot, O. (2009) Fibrillation atriale et insuffisance cardiaque: Une redoutable association de malfaiteurs. Annales de Cardiologie et d’Angéiologie, 58, S14-S16. https://doi.org/10.1016/s0003-3928(09)73391-8
[5]
Yassine, R., Chafia, C., Ayoub, E.L. and Rachida, H. (2017) Epidemiology of the Association between Atrial Fibrillation and Heart Failure. Pan African Medical Journal, 26, 116. https://doi.org/10.11604/pamj.2017.26.116.11470
[6]
Pellman, J. and Sheikh, F. (2015) Atrial Fibrillation: Mechanisms, Therapeutics, and Future Directions. In: Prakash, Y.S., Ed., Comprehensive Physiology, Wiley, 649-665. https://onlinelibrary.wiley.com/doi/10.1002/cphy.c140047 https://doi.org/10.1002/cphy.c140047
[7]
Carlisle, M.A., Fudim, M., DeVore, A.D. and Piccini, J.P. (2019) Heart Failure and Atrial Fibrillation, Like Fire and Fury. JACC: Heart Failure, 7, 447-456. https://doi.org/10.1016/j.jchf.2019.03.005
[8]
Santhanakrishnan, R., Wang, N., Larson, M.G., Magnani, J.W., McManus, D.D., Lubitz, S.A., et al. (2016) Atrial Fibrillation Begets Heart Failure and Vice Versa. Circulation, 133, 484-492. https://doi.org/10.1161/circulationaha.115.018614
[9]
Ben Halima, M., Mechri, M., Sammoud, K., Mourali, M.S., Kammoun, I., Bezdah, L., et al. (2020) Epidemiological Profile and Pronostic Impact of Patients with Heart Failure and Atrial Fibrillation: Results from the NATURE HF Registry. Archives of Cardiovascular Diseases Supplements, 12, 46. https://doi.org/10.1016/j.acvdsp.2019.09.096
[10]
Yameogo, N.V. (2012) Non-Valvular Atrial Fibrillation. A Case Report of 118 Observations from the Dakar University Hospital. Black African Medicine, 279-284.
[11]
Kingué, S., Ba, S.A., Balde, D., Diarra, M.B., Anzouan-Kacou, J., Anisubia, B., et al. (2016) The VALVAFRIC Study: A Registry of Rheumatic Heart Disease in Western and Central Africa. Archives of Cardiovascular Diseases, 109, 321-329. https://doi.org/10.1016/j.acvd.2015.12.004
[12]
Affangla1, D.A., Thiam1, N.N., et al. (2023) Atrial Fibrillation: Epidemiological, Etiological and Hospital Management Aspects in Thies (Senegal). World Journal of Cardiovascular Diseases, 13, 527-533.
[13]
Denham, N.C., Pearman, C.M., Caldwell, J.L., Madders, G.W.P., Eisner, D.A., Trafford, A.W., et al. (2018) Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure. Frontiers in Physiology, 9, Article 1380. https://doi.org/10.3389/fphys.2018.01380
[14]
Goyal, P., Almarzooq, Z.I., Cheung, J., Kamel, H., Krishnan, U., Feldman, D.N., et al. (2018) Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction: Insights on a Unique Clinical Phenotype from a Nationally-Representative United States Cohort. International Journal of Cardiology, 266, 112-118. https://doi.org/10.1016/j.ijcard.2018.02.007
[15]
Dye, C., Dela Cruz, M., Larsen, T., Nair, G., Marinescu, K., Suboc, T., et al. (2023) A Review of the Impact, Pathophysiology, and Management of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction. American Heart Journal Plus: Cardiology Research and Practice, 33, Article 100309. https://doi.org/10.1016/j.ahjo.2023.100309
[16]
Sangaré, I., Sagara, I., Keita, A., Konaté, M., Sidibé, N. and Sonfo, B. (2022) Clinical Features and Management of Inpatients with Atrial Fibrillation at the University Teaching Hospital Gabriel Toure. Sciences de la Santé et Maladies, 23, 77-80.
[17]
Stambler, B. and Ngunga, L. (2015) Atrial Fibrillation in Sub-Saharan Africa: Epidemiology, Unmet Needs, and Treatment Options. International Journal of General Medicine, 2015, 231-242. https://doi.org/10.2147/ijgm.s84537
[18]
Samoura, A., Camara, A., Samoura, S., Beavogui, M., Soumaoro, M., Koivogui, D., et al. (2019) An Atrial Fibrillation during Arterial Hypertension in the Cardiology Department of the Ignace Deen National Hospital, CONAKRY CHU. Cardiology & Vascular Research, 3, 1-4.
[19]
Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V., et al. (2001) Prevalence of Diagnosed Atrial Fibrillation in Adults. Journal of the American Medical Association, 285, Article 2370. https://doi.org/10.1001/jama.285.18.2370
[20]
Schrage, B., Geelhoed, B., Niiranen, T.J., Gianfagna, F., Vishram‐Nielsen, J.K.K., Costanzo, S., et al. (2020) Comparison of Cardiovascular Risk Factors in European Population Cohorts for Predicting Atrial Fibrillation and Heart Failure, Their Subsequent Onset, and Death. Journal of the American Heart Association, 9, e015218. https://doi.org/10.1161/jaha.119.015218
[21]
Camara, A., Samoura, A., Samoura, S., Koivogui, D., Bah, A., Diaby, M., et al. (2019) Epidemiological and Clinical Aspects in the Cardiology Department of the Ignace Deen National Hospital CHU of Conakry. Cardiology & Vascular Research, 3, 1-4.
[22]
Tzeis, S., Gerstenfeld, E.P., Kalman, J., Saad, E.B., Shamloo, A.S., Andrade, J.G., et al. (2024) 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm, 21, e31-e149. https://doi.org/10.1016/j.hrthm.2024.03.017
[23]
Joglar, J.A., Chung, M.K., Armbruster, A.L., Benjamin, E.J., et al. (2024) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, Article 1193. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193
[24]
McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Böhm, M., et al. (2021) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 42, 3599-3726.
